Prosecution Insights
Last updated: July 17, 2026

Cosud Intellectual Property Solutions, P.C.

5 pending office actions • 3 clients • 5 examiners • 5 art units • 0 of 5 (0%) have an AI response strategy ready • 8 patents granted in the last 365 days

Quality Metrics (n=2759 apps, methodology: how we score firms)

76.3%
Allowance Rate
n=2759
+0.62σ
Allowance Rate (norm)
n=2759
2.8
OAs to Allowance
n=1491
-0.42σ
OAs to Allow (norm)
n=1491
1076 days
Time to Allowance
n=1491
+10.6pp
Interview Lift
n=2759
14.3%
RCE Rate
n=2759
1.9%
Appeal Rate
n=2759

Rejection Performance (% of received rejections ultimately overcome)

§101 Overcome
n=18 (min 20)
85.0%
§102 Overcome
n=160
78.3%
§103 Overcome
n=701
91.8%
§112 Overcome
n=232

Specialization & Scale

A61K, A61P, A61B
Top CPC Subclasses
22%
Top-3 CPC Share
n=2759
1
Practitioners
n=2759
2759.0
Apps / Practitioner
n=2759

Portfolio Summary

5
Total Pending OAs
4
Non-Final OAs
1
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

1
Overdue
0
Due this week
0
Due this month
0
Due in next 60 days
0
Due later

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
5
Medium (100%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§103 only5 (100%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

4
Life Sciences
80% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
1
Semiconductors
20% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

50 h
Manual time on pending OAs
10 h
Time saved (low, 20%)
18 h
Time saved (mid, 35%)
0.4 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
HOLLINGTON, JERMELE M 1 86.0% -15.3%
NGUYEN, JOHN P 1 44.3% +41.3%
SCHLIENTZ, LEAH H 1 41.9% +38.9%
ABDALHAMEED, MANAHIL MIRGHANI ALI 1 51.1% +42.9%
HENLEY III, RAYMOND J 1 83.5% +2.3%

Quick Wins (2)

Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 2 ordered by deadline are shown.

App #TitleExaminerDue in
18888510 ELECTRICAL IMPEDANCE SPTROSCOPY FOR NON-DESTRUCTIVE, REAL-TIME, TRACKING OF RELATIVE WATER CONTENT AND STRESS RESPONSE IN PLANTS HOLLINGTON, JERMELE M
17767173 EARLY MANAGEMENT, MITIGATION and PREVENTION OF SEPSIS and SEPSIS-LIKE SYNDROMES, INCLUDING NEO-NATAL ARDS DUE TO INFECTION, INJURY or IATROGENESIS HENLEY III, RAYMOND J

Interview Candidates (3)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.

App #TitleExaminerDue in
17927917 NON-INVASIVE AND LONGITUDINAL MONITORING OF MICROGLIAL ACTIVATION IN RAT BRAIN WITH SUPERMAGNETIC NANOPARTICLE ENHANCED MR IMAGING SCHLIENTZ, LEAH H 89d overdue
18073852 DRUG THERAPY TO INHIBIT CHEMOTHERAPY-INDUCED ADVERSE EFFECTS AND RELATED PHARMACEUTICAL COMPOSITIONS, DIAGNOSTICS, SCREENING TECHNIQUES AND KITS NGUYEN, JOHN P
17801486 TREATMENT FOR CHEMOBRAIN ABDALHAMEED, MANAHIL MIRGHANI ALI

Client Portfolio (3 clients)

Client (Assignee)Pending OAs
UNM RAINFOREST INNOVATIONS 2
Yale University 2
Ophirex, Inc. 1

Top Art Units

Art UnitApps
28581
16191
16181
16221
16291

Pending Office Actions

App #TitleClientExaminerArt UnitStatutesStatusDue inAIFiled
18888510 ELECTRICAL IMPEDANCE SPTROSCOPY FOR NON-DESTRUCTIVE, REAL-TIME, TRACKING OF RELATIVE WATER CONTENT AND STRESS RESPONSE IN PLANTS UNM RAINFOREST INNOVATIONS HOLLINGTON, JERMELE M 2858 §103 Non-Final OA Pending Sep 18, 2024
18073852 DRUG THERAPY TO INHIBIT CHEMOTHERAPY-INDUCED ADVERSE EFFECTS AND RELATED PHARMACEUTICAL COMPOSITIONS, DIAGNOSTICS, SCREENING TECHNIQUES AND KITS Yale University NGUYEN, JOHN P 1619 §103 Non-Final OA Pending Dec 02, 2022
17927917 NON-INVASIVE AND LONGITUDINAL MONITORING OF MICROGLIAL ACTIVATION IN RAT BRAIN WITH SUPERMAGNETIC NANOPARTICLE ENHANCED MR IMAGING UNM RAINFOREST INNOVATIONS SCHLIENTZ, LEAH H 1618 §103 Non-Final OA 89d overdue Pending Nov 28, 2022
17801486 TREATMENT FOR CHEMOBRAIN Yale University ABDALHAMEED, MANAHIL MIRGHANI ALI 1622 §103 Final Rejection Pending Aug 22, 2022
17767173 EARLY MANAGEMENT, MITIGATION and PREVENTION OF SEPSIS and SEPSIS-LIKE SYNDROMES, INCLUDING NEO-NATAL ARDS DUE TO INFECTION, INJURY or IATROGENESIS Ophirex, Inc. HENLEY III, RAYMOND J 1629 §103 Non-Final OA Pending Apr 07, 2022

Managing Cosud Intellectual Property Solutions, P.C.'s Patent Prosecution?

IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month